Projects funded by the NCN
Piperazine derivatives as active histamine H3 receptor ligands - molecular modeling, synthesis, pharmacological evaluation
2016/23/N/NZ7/00469
Keywords:
histamine H3 receptors piperazines selective antagonists/inverse agonists
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 12 - announced on 2016-09-15
Amount awarded: 141 600 PLN
Project start date (Y-m-d): 2017-09-01
Project end date (Y-m-d): 2021-02-28
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.